- Home
- ZURA vs LOAN Comparison
ZURA vs LOAN Comparison
Compare ZURA & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- LOAN
- Stock Information
- Founded
- ZURA 2022
- LOAN 1989
- Country
- ZURA United States
- LOAN United States
- Employees
- ZURA N/A
- LOAN N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- LOAN Real Estate Investment Trusts
- Sector
- ZURA Health Care
- LOAN Real Estate
- Exchange
- ZURA Nasdaq
- LOAN Nasdaq
- Market Cap
- ZURA 69.9M
- LOAN 61.5M
- IPO Year
- ZURA N/A
- LOAN 1999
- Fundamental
- Price
- ZURA $1.92
- LOAN $5.35
- Analyst Decision
- ZURA Buy
- LOAN
- Analyst Count
- ZURA 10
- LOAN 0
- Target Price
- ZURA $12.67
- LOAN N/A
- AVG Volume (30 Days)
- ZURA 309.4K
- LOAN 21.1K
- Earning Date
- ZURA 11-06-2025
- LOAN 10-22-2025
- Dividend Yield
- ZURA N/A
- LOAN 8.70%
- EPS Growth
- ZURA N/A
- LOAN N/A
- EPS
- ZURA N/A
- LOAN 0.48
- Revenue
- ZURA N/A
- LOAN $7,300,469.00
- Revenue This Year
- ZURA N/A
- LOAN N/A
- Revenue Next Year
- ZURA N/A
- LOAN $4.47
- P/E Ratio
- ZURA N/A
- LOAN $11.01
- Revenue Growth
- ZURA N/A
- LOAN N/A
- 52 Week Low
- ZURA $0.97
- LOAN $4.74
- 52 Week High
- ZURA $5.07
- LOAN $6.05
- Technical
- Relative Strength Index (RSI)
- ZURA 53.10
- LOAN 53.44
- Support Level
- ZURA $1.97
- LOAN $5.30
- Resistance Level
- ZURA $2.19
- LOAN $5.44
- Average True Range (ATR)
- ZURA 0.12
- LOAN 0.10
- MACD
- ZURA -0.15
- LOAN -0.29
- Stochastic Oscillator
- ZURA 84.18
- LOAN 98.52
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About LOAN Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.